Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-25-009796)

Filing Details

Accession Number:: 0001127602-25-009796
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-18 16:37:08
Reporting Period:: 2025-03-17

Filing Date:: 2025-03-18
Accepted Time:: 2025-03-18 16:37:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882095	Gilead Sciences Inc.	GILD	Biological Products, (No Disgnostic Substances) (2836)	943047598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310204	D Andrew Dickinson	Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404	Chief Financial Officer	No	Yes	No	No

Transaction Summary

Sold:	2,500 shares	Avg. Price: $110.53	Total Value: $276,325.00
Number of Shares After Transactions:	170,674 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-03-17	2,500	$110.53	170,674	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

	
		OSZAR »